Journal article
Heritable methylation marks associated with breast and prostate cancer risk
Pierre-Antoine Dugue, James G Dowty, Jihoon E Joo, Ee M Wong, Enes Makalic, Daniel F Schmidt, Dallas R English, John L Hopper, John Pedersen, Gianluca Severi, Robert J MacInnis, Roger L Milne, Graham G Giles, Melissa C Southey
PROSTATE | WILEY | Published : 2018
DOI: 10.1002/pros.23654
Abstract
BACKGROUND: DNA methylation can mimic the effects of germline mutations in cancer predisposition genes. Recently, we identified twenty-four heritable methylation marks associated with breast cancer risk. As breast and prostate cancer share genetic risk factors, including rare, high-risk mutations (eg, in BRCA2), we hypothesized that some of these heritable methylation marks might also be associated with the risk of prostate cancer. METHODS: We studied 869 incident prostate cancers (430 aggressive and 439 non-aggressive) and 869 matched controls nested within a prospective cohort study. DNA methylation was measured in pre-diagnostic blood samples using the Illumina Infinium HM450K BeadChip. C..
View full abstractRelated Projects (2)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
National Health and Medical Research Council, Grant numbers: 1026892, 1061177, 209057, 396414; Cancer Council Victoria